Elsulfavirine

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameElsulfavirine
Drug Alias NameElpivirine艾法韦林ElpidaRO-5011500RO-4970335 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHuman immunodeficiency virus type 1 reverse transcriptase inhibitors
TargetsHuman immunodeficiency virus type 1 reverse transcriptase
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)HIV Infections
Global Approved IndicationsHIV Infections
Approved Indications in ChinaN/A
Original Approved Country/TerritoryRussian Federation
Original Approved Date2017/06/30
Country/TerritoryUnited StatesThailandRussian Federation
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesViriom Inc
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)HIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeJ05A
Related LinksN/A